) The goals of the Biostatistics and Data Management Core are to provide statistics and data management services to support research conducted by the project investigators. Core members include biostatisticians and data management and computing professionals from the Department of Biostatistics and Epidemiology and Center for Clinical Epidemiology and Biostatistics at Penn. Dr. Kathleen Joy Propert, Assistant Professor of Biostatistics, will serve as the Core Director overseeing all activities and personnel.
The specific aims of the Biostatistics and Data Management Core are: (1) Biostatistics: (a) Advise investigators on study design issues for clinical protocols, animal studies, and other research. (b) Conduct interim analyses and assist with writing of interim reports as required for data and safety monitoring of clinical protocols. (c) Conduct statistical analyses of data from clinical and laboratory projects to address specific research hypotheses as defined in the project-specific proposals. (d) Assist with preparation for and writing of final reports, abstracts, manuscripts, and future research proposals. (e) Conduct exploratory analyses that may lead to generation of new hypotheses. (2) Data Management: (a) Implement a framework to facilitate data management and statistical analysis for all projects by establishing interaction among biostatisticians, data management specialists, computing and database personnel, and project investigators. (b) Design and implement procedures for enrolling patients to clinical projects and tracking the flow of data through various study phases. (c) Develop and implement procedures for case report forms design and coding, data entry and validation, quality assurance, and reporting. (d) Design, test, implement, and maintain database structures and application programs to support Aims 2b and 2c.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA066726-06
Application #
6443345
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2001-04-03
Project End
2002-03-31
Budget Start
Budget End
Support Year
6
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Moon, Edmund K; Wang, Liang-Chuan S; Bekdache, Kheng et al. (2018) Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines. Oncoimmunology 7:e1395997
Aggarwal, Charu; Haas, Andrew R; Metzger, Susan et al. (2018) Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion. Mol Ther 26:1198-1205
Klampatsa, Astero; Haas, Andrew R; Moon, Edmund K et al. (2017) Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM). Cancers (Basel) 9:
Moon, Edmund K; Ranganathan, Raghuveer; Eruslanov, Evgeniy et al. (2016) Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer. Clin Cancer Res 22:436-47
Liu, X; Barrett, D M; Jiang, S et al. (2016) Improved anti-leukemia activities of adoptively transferred T cells expressing bispecific T-cell engager in mice. Blood Cancer J 6:e430
Liu, Xiaojun; Ranganathan, Raghuveer; Jiang, Shuguang et al. (2016) A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors. Cancer Res 76:1578-90
O'Hara, Mark; Stashwick, Caitlin; Haas, Andrew R et al. (2016) Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy. Immunotherapy 8:449-60
Sterman, Daniel H; Alley, Evan; Stevenson, James P et al. (2016) Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFN? Combined with Chemotherapy. Clin Cancer Res 22:3791-800
Newick, Kheng; O'Brien, Shaun; Sun, Jing et al. (2016) Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization. Cancer Immunol Res 4:541-51
Andy, Uduak U; Harvie, Heidi S; Smith, Ariana L et al. (2015) Validation of a self-administered instrument to measure adherence to anticholinergic drugs in women with overactive bladder. Neurourol Urodyn 34:424-8

Showing the most recent 10 out of 85 publications